Lc. Harrison et al., INVERSE RELATION BETWEEN HUMORAL AND CELLULAR-IMMUNITY TO GLUTAMIC-ACID DECARBOXYLASE IN SUBJECTS AT RISK OF INSULIN-DEPENDENT DIABETES, Lancet, 341(8857), 1993, pp. 1365-1369
Glutamic acid decarboxylase (GAD) in pancreatic beta cells is an autoa
ntigen in insulin-dependent diabetes (IDD). We measured immunity to GA
D in 31 first-degree relatives of IDD patients judged to be at risk of
developing IDD themselves because of the presence of islet-cell antib
odies. We found that in most of the subjects GAD autoimmunity was eith
er predominantly humoral or predominantly cellular. High concentration
s of circulating autoantibodies that precipitate native GAD activity w
ere associated with low proliferation of peripheral-blood T cells to r
ecombinant GAD; conversely, low concentrations of autoantibody to GAD
were associated with high T-cell proliferation to GAD. Although T-cell
proliferation was measured in the presence of autologous serum, GAD a
utoantibodies did not have a blocking effect in vitro. This dichotomy
of the immune response to GAD defined heterogeneity within at-risk rel
atives and could have prognostic importance. We postulate that, if GAD
is a pathogenetic autoantigen, sensitisation to beta-cell GAD is more
likely to lead to IDD when the immune response deviates towards the e
xpansion of autoreactive T cells rather than towards generation of aut
oantibodies. This idea is consistent with evidence that beta-cell dest
ruction is mediated by T cells and that high concentrations of GAD ant
ibodies are associated with slower progression to clinical disease.